Phase I-II Evaluation of Emetine (NSC-33669) in the Treatment of Epidermoid Bronchogenic Carcinoma

Overview

Journal Cancer Chemother Rep

Specialties Oncology
Pharmacology

Date 1975 Nov 11

PMID 1222395

Citations 11

Authors

R C Kane

M H Cohen

L E Broder

M I Bull

P J Creaven

B E Fossieck Jr

Affiliations

Soon will be listed here.

Citing Articles

Silva S, Dias I, Rodrigues A, Costa R, Oliveira M, Barbosa G Cell Death Discov. 2024; 10(1):201.

PMID: 38684672 PMC: 11059384. DOI: 10.1038/s41420-024-01967-8.

Peng X, Shi J, Zhao Z, Tong R, Zhang X, Zhong L Cancer Chemother Pharmacol. 2023; 91(4):303-315.

PMID: 36941385 PMC: 10027284. DOI: 10.1007/s00280-023-04521-y.

Valipour M, Irannejad H, Emami S Cell Cycle. 2022; 21(22):2379-2386.

PMID: 35852390 PMC: 9645258. DOI: 10.1080/15384101.2022.2100575.

Hirt C, Booij T, Grob L, Simmler P, Toussaint N, Keller D Cell Genom. 2022; 2(2):100095.

PMID: 35187519 PMC: 7612395. DOI: 10.1016/j.xgen.2022.100095.

Angeles C, Velez A, Rios J, Laxa B, Shum D, Ruiz P Clin Cancer Res. 2021; 28(1):175-186.

PMID: 34667024 PMC: 9265140. DOI: 10.1158/1078-0432.CCR-19-2486.